Stereotactic body radiation therapy versus more fractionated radical radiotherapy for adults with stage I/II non-small cell lung cancer: a systematic review and network meta-analysis-Reference-Cited by-同舟云学术

Stereotactic body radiation therapy versus more fractionated radical radiotherapy for adults with stage I/II non-small cell lung cancer: a systematic review and network meta-analysis

Published:2022-04-08 Issue:4 Volume:2022 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Zhao Ye¹,Feng Hai-ming²,Tian JinHui³,Li Bin²,Wang Cheng²,Ge Long³,Feng Shi-fang⁴,Yu Qin¹

Affiliation:

1. First Clinical Medical College; Lanzhou University; Lanzhou City, Gansu Province China

2. Department of Thoracic Surgery, The Second Affiliated Hospital of Lanzhou University; Lanzhou University; Lanzhou City, Gansu Province China

3. Evidence-Based Medicine Center, School of Basic Medical Sciences; Lanzhou University; Lanzhou City China

4. Department of Radiotherapy; People’s Hospital of Gansu Province; Lanzhou City, Gansu Province China

Publisher

Wiley

Subject

Pharmacology (medical)

Reference114 articles.

1. The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology;Aaronson;Journal of the National Cancer Institute,1993

2. Lung cancer (non-small cell). American Cancer Society (ACS) www.cancer.org/cancer/non-small-cell-lung-cancer.html

3. Optimal tumor control for early-stage non-small-cell lung cancer: a radiobiological modelling perspective;Alaswad;European Journal of Medical Physics,2019

4. Non-vitamin K antagonist oral anticoagulants (NOACs) post-percutaneous coronary intervention: a network meta-analysis Cochrane Database of Systematic Reviews 2019 12 10.1002/14651858.CD013252.pub2

5. Stereotactic body radiotherapy as primary therapy for head and neck cancer in the elderly or patients with poor performance;Amini;Frontiers in Oncology,2014